key: cord-0743098-j128pcf8
authors: Bhakta, Shivang; Erben, Young; Sanghavi, Devang; Fortich, Susana; Li, Yupeng; Hasan, Mohammed M.; Dong, Yue; Brigham, Tara J.; Edwards, Michael A.; Meschia, James F.; Franco, Pablo Moreno
title: A Systematic Review and Meta-Analysis on Racial Disparities in Deep Venous Thrombosis and Pulmonary Embolism Events in COVID-19 Hospitalized Patients
date: 2022-03-17
journal: J Vasc Surg Venous Lymphat Disord
DOI: 10.1016/j.jvsv.2022.03.003
sha: 5aa0944d1a7880c89bcbe6a05635e94e7780ea3d
doc_id: 743098
cord_uid: j128pcf8

Objective COVID-19 is associated with an increased risk of venous thromboembolic events (VTE). Recent studies have characterized racial disparities in the incidence of VTE. The aim of our study was to present a systematic review and meta-analysis to assess the association between race and VTE in hospitalized COVID-19 patients. Methods We performed a systematic literature review to evaluate the number of deep vein thrombosis (DVT) and pulmonary embolism (PE) events reported by racial groups in COVID-19 hospitalized patients. For qualitative analysis, independent reviewers extracted data from eligible studies, and we utilized the Newcastle-Ottawa Scale to assess the quality of design and content for accurate interpretation. For the quantitative analysis, we pooled the ORs with Der Simonian and Laird random effects models. Results The qualitative analysis included 11 studies, and the meta-analysis had six of them. All studies were observational, retrospective cohort studies, except for one retrospective case-control study. Six studies were eligible for the meta-analysis due to high interstudy heterogeneity; thus, variable reports of racial groups reduced the cohort to Black/African American and White patients (n = 9723) in the analysis. The estimated proportion for DVT/PE for Black/African American and Whites was 0.07 (95% CI [0.00, 0.10]) and 0.04 (95% CI [0.00, 0.07]), respectively. The p value of 0.13 suggest non-significant difference in VTE rates between Black/African American and White patients. Conclusion In our study, the proportion of DVT/PE events between Black/African American and White COVID-19 patients were comparable. Future COVID-19 studies should include systematic racial group reporting to identify disparities in the setting of thromboembolic events.

4 also searched the grey literature resources. There were no limits to language or publication date. 1

We placed filters to exclude pediatric and animal-related studies. The search strategies consisted 2 of a combination of keywords and standardized index terms. The search terms included MeSH, 3

Embase/ Emtree terms, as well as keywords such as COVID-19, SARS-COV-2, deep vein 4 thrombosis (DVT), pulmonary embolism (PE), African American, black individuals, as well as 5 terms associated with racial and ethnic disparities. We searched all databases and grey literature 6 resources on July 22, 2021. The full search strategies are available here: https://osf.io/cxw2p. 7

The librarian downloaded the results into EndNote 9.0 (Clarivate, Philadelphia, Pennsylvania, 8 USA), a bibliographic database manager. The methods outlined in Bramer et al 27 helped to 9 identify and remove any duplicate citation. Two reviewers (SB, MMH) independently screened 10 the titles and abstracts for relevance. A third reviewer (SF) settled any disagreements. The 11 reviewers assessed relevant articles in full-text to determine eligibility using the following 12 inclusion criteria: (a) interventional or observational studies in adult humans, (b) studies 13 reporting racial groups in DVT and PE events in patients with and (c) articles 14 written in English language. Studies with composite outcomes were eligible if the corresponding 15 author could provide the raw dataset of patient subgroup solely with DVT and/or PE events. The 16 exclusion criteria were the following: (a) pre-print articles, (b) review articles, book sections, 17 congress abstracts, case series, and case reports, and (c) studies reporting postmortem events. A 18 descriptive narrative of 10 patients or less defined a case series in our study. 19

The data extracted from the eligible studies included study details (e.g., author's first 21 name, date and country of publication, study design), patient characteristics (e.g., number of 22 patients, gender, age, COVID-19 diagnostic method), use of thromboprophylaxis/anticoagulation 23 J o u r n a l P r e -p r o o f 5 before the outcome of interest, and venous thromboembolic events by racial groups. Two 1 reviewers (SB, MMH) independently extracted the data, and they resolved any disagreements by 2 consensus. 3

The primary outcome was the estimated VTE proportion, defined as DVT and PE in 4 COVID-19 patients according to racial/ groups. To assess the quality of nonrandomized studies 5 in the meta-analysis, we used the Newcastle-Ottawa Scale (NOS). A star-based system to 6 evaluate case-control and cohort studies included the following sections: selection of study 7 groups, the comparability of groups, and the ascertainment of exposure/outcome of interest for 8 case-control or cohort studies. Studies allotted with a score of seven or greater were high quality 9 research or low risk of bias. Two independent reviewers (SB, SF) assessed the quality of the 10 studies. Consensus resolved any disagreements, and if necessary, the decision of a third author 11 was definitive. 12

We performed a meta-analysis to assess the relationship between race (Black/African American 14 and Whites) and occurrence of VTE. Regarding major outcomes, we pooled ORs with Der 15

Simonian and Laird random effects models being used for sensitivity analysis. We calculated 16 P values to evaluate for statistical significance, with a P value of less than .05 indicating a 17 statistically significant difference. All statistical analyses used the absolute values and not 18 percentages. We applied the Hedges estimator and the Sidik-Jonkman estimator to assess the risk 19 of publication bias. We used SAS statistical software version 9.4 (SAS Institute, Cary, NC) to 20 perform all statistical analysis and forest plots. The electronic search yielded 815 manuscripts. After removing duplicates, the reviewers 2 screened 578 titles and abstracts. They also reviewed 48 articles and an additional 49 studies 3 identified from citation searching in full text to assess eligibility. Of those, 11 studies fulfilled 4 our inclusion criteria. We excluded a total of 86 articles, which comprised 7 pre-print studies, 2 5 review articles, 1 case series, 8 studies that did not report number of DVT/PE, and 68 studies that 6 did not report DVT/PE events by racial groups (Figure 1 ). Using the Newcastle-Ottawa scale, 12 7 4 (36.4%) studies were at high risk of bias, and 7 (63.6%) were at low risk of bias. We included 8 the quality assessment of the 11 studies in the Supplementary Table II.  9 The 11 eligible studies were observational, 10 of which were retrospective cohorts and 1 10 was a retrospective case-control study. We identified 10 studies that were conducted in the 11

United States except for one study conducted in the United Kingdom. Polymerase chain reaction 12 (PCR) determined the COVID-19 status of patients. These 11 studies included a total of 20,023 patients with a proportion of 27-54.2% of female 14 patients. DVT and PE was a single outcome termed VTE in 5 studies and of those, a single study 15 reported VTE and mortality as a composite primary outcome. Two studies reported DVT and PE 16 as independent events. Four of the retrospective analysis evaluated either DVT or PE only as an 17 outcome. The documentation of racial groups was variable. Ranging from 1-5 racial groups, 18 7 We conducted a meta-analysis combining 6 manuscripts reporting a proportion of 1 DVT/PE rate distributed according to race. Due to expected heterogeneity, we adopted the 2 random-effects model with inverse variances weight to do the estimation, and therefore taking 3 both within-and between-study variances into account. Since the observed proportions were not 4 skewed, we did not apply transformations to the data. We utilized the DerSimonian-Laird 5 estimator for our random-effect model. 24 We could only analyze the primary outcome between 6 Black/African American and White patients, as other racial groups were not reported 7 consistently. The estimated proportion of VTE events for Black/African American and Whites 8 was 0.07 and 0.04 respectively and the 95% confidence interval stretches from 0.00 to 0.10, and 9 0.00 to 0.07. The p value (0.13) suggested a non-significant difference in VTE rates between 10 Black/African American and White race. For publication bias purposes, we performed both the 11

Hedges estimator and the Sidik-Jonkman estimator, which delivered consistent results as the DL 12 estimator (Figure 2 In this review based on racial disparities, the overall 23 J o u r n a l P r e -p r o o f 8 proportion of DVT/PE events for COVID-19 patients was lower than those reported in other 1 COVID-19 meta-analysis. 6,7,27,28 2 Thromboembolism in COVID-19 patients is associated with poor clinical outcomes, 25,29 3 but its true incidence in different racial groups has not been reported consistently. The result of 4 this study does not support the hypothesis that Black/African American patients have a higher 5 risk for developing DVT/PE. Of note, prior to the pandemic, several studies reported a 2-fold 6 higher VTE event rate in Black/African American attributed to a higher prevalence of 7 comorbidities, higher body mass index, poor educational level, low socioeconomic status, among 8 others. 10, 11, 30 It has also been reported that procoagulant proteins like Factor VIII and von 9

Willebrand factor as well as D-dimer levels are reported in higher concentrations in 10 Black/African American patients. 9 The presence of high interstudy heterogeneity in our 11 systematic review restricted the quantitative analysis. The studies included report in varying 12 degrees relevant patient characteristics including comorbid conditions, clinical severity of 13 infection, relevant laboratory data, need for oxygen therapy, VTE risk stratification and 14 prophylaxis, and other important outcomes that could have been influenced/be different across 15 racial groups. The inability to adjust for potential confounding bias between the racial groups is a 16 major limitation. Therefore, we recommend uniform, systematic reporting standards in future 17 studies related to COVID-19 infection and race. Moreover, higher mortality has been reported in 18 black patients probably due to undiagnosed thrombotic events. Postmortem studies have shown 19 that 22-58% of patients had evidence of DVT and PE. 31,32 20

Several other limitations noted are the lack of well-designed studies geared towards the 21 noted racial and social inequalities that the COVID-19 pandemic exposed. . Perhaps, these 22

inequalities have contributed to our underpowered study that would have required a cohort of 23 J o u r n a l P r e -p r o o f 9 approximately 565 Black/African-American patients in order to demonstrate a racial disparity. 1

Further, the studies included in the meta-analysis represent a small cohort published from 2 October 2020 to June 2021, thus limiting the experience. Finally, many hospital practices 3 regarding anticoagulation and prophylaxis in COVID-19 patients have been modified throughout 4 the pandemic and this might have added confounders during the data analysis. Studies included 5 were reports from the United States and United Kingdom only, which further limits the 6 generalizability of our findings. Another limitation was the lack of standardization and 7 uniformity in terms of reporting for racial differences/disparities, which led to the exclusion from 8 the meta-analysis of at least 5 other studies. Lastly, there was a lack of standardization of 9 DVT/PE risk stratification and prophylaxis in these studies, especially in this hypercoagulable 10 cohort of patients, which impairs the analysis of the published data. 11

The available evidence on the proportion of DVT/PE events in Black/African American 14 and White patients demonstrate no significant difference between racial groups. The estimated 15 proportion DVT/PE overall was lower than in data presented in previous meta-analysis. Further 16 endeavors in the application of uniform racial group definitions and reporting standards should 17 be considered to allow for comparisons, specifically for thromboembolic events. Charoenngam N, Ilori TO, Holick MF, Hochberg NS, Apovian CM. Self-identified Race 9

and COVID-19-Associated Acute Kidney Injury and Inflammation: a Retrospective 10 J o u r n a l P r e -p r o o f 

Utility of d-dimer 12 for diagnosis of deep vein thrombosis in coronavirus disease-19 infection

Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19

The effect of 18 race on composite thrombotic events in patients with COVID-19